Skip to main content

Want a detailed portfolio tracker?

Invizyne Technologies (EXOZ) P/E (2024 - 2026)

Invizyne Technologies (EXOZ) P/E from Nov 13, 2024 to Jul 21, 2026. The TTM Invizyne Technologies (EXOZ) P/E is -4.63. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Invizyne Technologies (EXOZ)

YearP/EChange
2026-4.63-53.58%
2025-9.97-47.75%
2024-19.09N/A

Comparison Invizyne Technologies (EXOZ) P/E with competitors

Invizyne Technologies (EXOZ) P/E is -4.63.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.62%
FGENFibroGen Inc0.24-105.19%
CHRSCoherus Biosciences Inc0.85-118.33%
FBIOFortress Biotech Inc0.95-120.50%
ORMPOramed Pharmaceuticals Inc1.50-132.47%
AGENAgenus Inc3.01-165.01%
INVAInnoviva Inc3.15-168.13%
VXRTVaxart Inc3.55-176.68%
CRMDCorMedix Inc3.63-178.38%
CVACCureVac N.V.4.45-196.03%
GLPGGalapagos NV4.86-204.96%
SRPTSarepta Therapeutics Inc4.88-205.46%
ABEOAbeona Therapeutics Inc5.39-216.38%
ABUSArbutus Biopharma Corp5.60-220.88%
ZVRAZevra Therapeutics Inc5.89-227.17%
SPROSpero Therapeutics Inc6.23-234.55%
CGENCompugen Ltd6.31-236.39%
RIGLRigel Pharmaceuticals6.87-248.45%
SLXNSilexion Therapeutics Corp7.30-257.61%
OMEROmeros Corporation9.26-300.01%
AUPHAurinia Pharmaceuticals Inc9.58-307.05%
PLXProtalix BioTherapeutics Inc10.89-335.27%
ACADAcadia Pharmaceuticals Inc11.73-353.36%
TBPHTheravance Biopharma Inc12.26-364.89%
ADMAAdma Biologics Inc12.42-368.26%
HRMYHarmony Biosciences Holdings Inc13.82-398.54%
SABSSAB Biotherapeutics Inc14.14-405.37%
NAGENiagen Bioscience Inc14.82-420.10%
INCYIncyte Corp15.82-441.80%
REGNRegeneron Pharmaceuticals Inc15.86-442.53%
PBYIPuma Biotechnology Inc17.32-474.05%
CPRXCatalyst Pharmaceuticals Inc17.44-476.72%
TGTXTG Therapeutics Inc18.97-509.70%
MDXGMimedx Group Inc20.55-543.97%
XOMAXOMA Royalty Corp22.87-594.15%
ARGXArgen X SE24.30-624.90%
CTMXCytomX Therapeutics Inc24.82-636.20%
XOMAOXOMA Royalty Corp25.34-647.51%
HALOHalozyme Therapeutics Inc25.62-653.54%
XOMAPXOMA Royalty Corp25.67-654.54%
VRTXVertex Pharmaceuticals Inc27.99-704.76%
RPRXRoyalty Pharma plc - Class A28.69-719.72%
SLNOSoleno Therapeutics Inc29.02-726.80%
ASNDAscendis Pharma A/S30.09-749.92%
LGNDLigand Pharmaceuticals Inc - Class B37.91-918.99%
APLSApellis Pharmaceuticals Inc39.02-942.96%
BMRNBiomarin Pharmaceutical Inc42.21-1011.88%
KRYSKrystal Biotech Inc45.34-1079.53%
ONCBeiGene Ltd69.54-1602.25%
PHARPharming Group N.V.75.03-1720.74%
TECHBio-Techne Corp101.96-2302.56%
VCELVericel Corp109.92-2474.58%
ALNYAlnylam Pharmaceuticals Inc117.96-2648.34%
GMABGenmab140.29-3130.63%
TLXTelix Pharmaceuticals Ltd162.15-3602.91%
CORTCorcept Therapeutics Inc212.86-4698.26%